CompaniesInvestorsPeople
Home
Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

  • Contact

  • Request a Demo

  • Request Data Updates

  • Add a Company

Research

  • Companies

  • Investors

  • People

aVenture

  • Download App

  • Pricing

Download the aVenture Research beta for iOS and iPadOSDownload aVenture Research on the Mac App Store

Resources

  • Documentation

  • Use Cases

  • CLI

  • MCP

  • Feature Requests

  • Sitemap

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading
Home›
Companies›
Ivrea Pharmaceuticals
Ivrea Pharmaceuticals logo

Ivrea Pharmaceuticals

Ivrea Pharmaceuticals: Specializing in dermatology prescriptions for conditions like acne, serving the US.

Quincy, MA, US🇺🇸
Founded
2005
Overview
Compare
Fundraising
Employees

Ivrea Pharmaceuticals specializes in developing prescription medications for dermatology conditions, including onychomycosis, acne, and photodamage. The company aims to provide effective treatments to improve skin health and serves the United States healthcare industry.

Ivrea Pharmaceuticals has made significant strides in dermatology, contributing to advancements in skin condition treatments. Their innovative products have positively impacted patient care, establishing the company as a notable player in the pharmaceutical sector.

Ivrea Pharmaceuticals - Similar Companies

Transport Pharmaceuticals logo

Transport Pharmaceuticals

Quinnova Pharmaceuticals logo

Quinnova Pharmaceuticals

quinnova.com

Verrica Pharmaceuticals logo

Verrica Pharmaceuticals

verrica.com

Sonoma Pharmaceuticals logo

Ivrea Pharmaceuticals - Quick Facts

Who are Ivrea Pharmaceuticals' competitors?

Companies similar to Ivrea Pharmaceuticals include Transport Pharmaceuticals, Quinnova Pharmaceuticals, Verrica Pharmaceuticals and Sonoma Pharmaceuticals.

When was Ivrea Pharmaceuticals founded?

Ivrea Pharmaceuticals was founded in 2005.

Where is Ivrea Pharmaceuticals' headquarters located?

Ivrea Pharmaceuticals' headquarters is located in Quincy, MA, US.

When was Ivrea Pharmaceuticals' last funding round?

Ivrea Pharmaceuticals' most recent funding round was for $5.1M (USD) in August 2005.

How much disclosed funding has Ivrea Pharmaceuticals raised?

As of Aug 5, 2005, Ivrea Pharmaceuticals has disclosed funding of $5.1M (USD). Undisclosed round amounts are excluded.

How many employees does Ivrea Pharmaceuticals have?

Ivrea Pharmaceuticals has 5 employees as of Feb 5, 2024.

Ivrea Pharmaceuticals - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Medication
  • Pharmaceuticals
Tags
  • Healthcare
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC

Sonoma Pharmaceuticals

sonomapharma.com

Eirion Therapeutics logo

Eirion Therapeutics

eirionthera.com

Timber Pharmaceuticals logo

Timber Pharmaceuticals

PellePharm logo

PellePharm

pellepharm.com

Novelix Pharmaceuticals logo

Novelix Pharmaceuticals

Nitric Bio logo

Nitric Bio

Aquavit Pharmaceuticals logo

Aquavit Pharmaceuticals

aquavitpharma.com

Microdermis logo

Microdermis

microdermis.com

Cosmederm Bioscience logo

Cosmederm Bioscience

cosmederm.com

Ionia Pharmacy logo

Ionia Pharmacy

Iacta Pharmaceuticals logo

Iacta Pharmaceuticals

Icvrx logo

Icvrx

2800
Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified